Page last updated: 2024-12-07

clidanac

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

clidanac: minor descriptor (75-89); on-line search INDENES & CYCLOHEXANES (71-74) & INDANS (75-89); INDEX MEDICUS search INDENES (71-89) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID120108
CHEMBL ID130393
CHEBI ID31411
SCHEMBL ID24379
MeSH IDM0164506

Synonyms (48)

Synonym
6-chloro-5-cyclohexyl-2,3-dihydro-1h-indene-1-carboxylic acid
dl-clidanac
(+-)-tai 284
tai 284
clidanaco [inn-spanish]
clidanacum [inn-latin]
(+-)-clidanac
1-indancarboxylic acid, 6-chloro-5-cyclohexyl-
clidanac [inn:jan]
dl-tai 284
indanal
britai
brn 2057663
6-chloro-5-cyclohexyl-1-indancarboxylic acid
1h-indene-1-carboxylic acid, 6-chloro-5-cyclohexyl-2,3-dihydro-
tai-284
clidanac
D01330
clidanac (jan/inn)
34148-01-1
CHEMBL130393
AKOS005137927
28968-07-2
6-chloro-5-cyclohexyl-indane-1-carboxylic acid
ua6hm01wak ,
clidanaco
unii-ua6hm01wak
clidanacum
6-chloro-5-cyclohexyl-1-indanecarboxylic acid
AM20040106
1h-indene-1-carboxylicacid, 6-chloro-5-cyclohexyl-2,3-dihydro-
SCHEMBL24379
(+/-)-tai-284
(+/-)-clidanac
clidanac, (+/-)-
clidanac [inn]
clidanac [jan]
clidanac [who-dd]
(+/-)-6-chloro-5-cyclohexylindane-1-carboxylic acid
clidanac [mi]
OIRAEJWYWSAQNG-UHFFFAOYSA-N
DTXSID2022834
CHEBI:31411
TQP1432
NCGC00538320-01
Q27290980
CS-0081379
HY-121292

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" At 3 h after dosing R(-)-I, the plasma contained above 90% of the S(+)-isomer."( Optical isomerization of R(-)-clidanac to the biologically active S(+)-isomer in guinea-pigs.
Kawai, K; Kishimoto, S; Kuzuna, S; Tamura, S, 1981
)
0.55
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID178647Antiinflammatory activity was evaluated in an carrageenan edema (acute inflammation) test, after administering compound orally in rats.1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Nonsteroidal antiinflammatory agents. 14. Synthesis and pharmacological profile of 6-chloro-5-(cyclopentylmethyl)indan-1-carboxylic acid.
AID177361Antiinflammatory activity was evaluated in an adjuvant arthritis (subchronic inflammation) test, after administering compound orally in rats.1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Nonsteroidal antiinflammatory agents. 14. Synthesis and pharmacological profile of 6-chloro-5-(cyclopentylmethyl)indan-1-carboxylic acid.
AID189983Gastrointestinal tolerability was evaluated under acute conditions, in rats. The ulcerogenic dose was reported.1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Nonsteroidal antiinflammatory agents. 14. Synthesis and pharmacological profile of 6-chloro-5-(cyclopentylmethyl)indan-1-carboxylic acid.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (28.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]